HIV-1 genotype (GHIV), HIV-1 Integrase (HIV1I) and HIV-1 Trophile (HIV1T) assays are sendout tests that incur a significant financial burden on the laboratory when ordered on inpatients who do not receive follow-up clinic visits. For these assays to be utilized in guiding antiretroviral therapy, the patient must receive follow-up. It will reduce the sendout budget by restricting these tests to the outpatient clinic setting.
Recommended CitationBiederman, MD, Laura and Roberts, PhD, D(ABMM), Amity L., "HIV Genotyping Cost Analysis with Follow-up as an Indicator" (2015). Department of Pathology, Anatomy, and Cell Biology Resident's Posters. Paper 27.